Candriam S.C.A. Dynavax Technologies Corp Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$15.15 - $20.75 $1.05 Million - $1.43 Million	-69,000 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$14.65 - $19.9 $161,150 - $218,899	-11,000 Reduced 13.75%	69,000 $1.37 Million
Q4 2017 Feb 07, 2018	SELL	$17.3 - $24.08 $2.82 Million - $3.93 Million	-163,000 Reduced 67.08%	80,000 $1.5 Million
Q3 2017 Nov 03, 2017	BUY	$15.2 - $21.5 $3.69 Million - $5.22 Million	243,000	243,000 $5.23 Million

288

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.74B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.